Cannabidiol (CBD) is a non-psychoactive substance found in the cannabis plant. It is widely used for its therapeutic effects, such as reducing anxiety, inflammation, pain, and other medical conditions. As research on CBD increases, it is essential to understand how it may interact with commonly prescribed medications, such as blood thinners (anticoagulants). In this article, we will examine the potential interactions between CBD and blood thinners, including two of the most popular: warfarin and Eliquis.
Anticoagulants and how they work
Anticoagulants are medications used to prevent blood clots from forming when a person suffers from thrombosis or stroke. They work by slowing blood clotting to allow blood to flow freely through the vessels. Two of the main anticoagulant medications on the market are warfarin and Eliquis.
Warfarin
Warfarin is a commonly prescribed oral anticoagulant that has been used for decades to prevent strokes and blood clots in high-risk patients. People with certain heart conditions, such as atrial fibrillation (an irregular heartbeat), artificial heart valves, or those who have recently undergone surgery, are often prescribed warfarin.
The Eliquis
Eliquis is another oral anticoagulant that inhibits blood clotting by blocking the action of a specific factor in the blood coagulation process. It is prescribed to prevent strokes and other complications in patients with conditions such as atrial fibrillation, pulmonary embolisms, and/or deep vein thrombosis.
CBD and its metabolism
In our bodies, CBD—like various other medications—is primarily metabolized by the cytochrome P450 when taken orally. Many of these enzymes also play a major role in the metabolism of other drugs, including certain anticoagulants such as warfarin and Eliquis.
Potential interactions between CBD and anticoagulants
Although studies on possible interactions between CBD and anticoagulants are still limited, some research suggests that cannabidiol could influence the level of these drugs in the body, which could lead to potential complications.
CBD and warfarin
A study published in the journal "Epilepsy & Behavior Case Reports" found that a child with Dravet syndrome—a rare form of childhood epilepsy—developed abnormal bleeding during combined treatment withoil (Epidiolex) and warfarin. The study suggests that CBD increased the plasma concentration of warfarin, highlighting the importance of carefully monitoring anticoagulant efficacy and therapeutic balance when CBD and warfarin are used together.
CBD and Eliquis
There is currently no specific research on the interactions between CBD and Eliquis. However, since cytochrome P450 also plays a role in the metabolism of Eliquis, it is plausible that the same type of interaction is possible. Therefore, caution should be exercised when consuming CBD concurrently with Eliquis.
Precautionary measures to be taken into account
- Consult a healthcare professional : Before starting or changing your CBD dosage, it is essential to consult a doctor or pharmacist who will take into account your current medications and general health.
- Close monitoring : For patients already taking anticoagulants, close monitoring of anticoagulant efficacy, plasma drug levels, and signs of bleeding or clotting is crucial when using CBD.
- Inform your doctor of any changes : If you experience side effects while using CBD and anticoagulants, talk to your doctor as soon as possible to adjust dosages or consider other treatment options.
In conclusion, although research on the interactions between CBD and anticoagulants is still limited, the available data suggest a significant potential for interaction that warrants careful attention. Consultation with a healthcare professional and careful monitoring of symptoms are essential to ensure the safety and efficacy of concomitant treatment with CBD and anticoagulant medications such as warfarin and Eliquis.
Editor-in-Chief specializing in CBD
Julien, born on July 17, 1978, in the Paris region, is a prominent writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
